|

Monoclonal antibody Clinical Trials

3 actively recruiting trials

Pipeline

Phase 1/2: 1

Top Sponsors

  • Sung-Soo Park2
  • Immunocore Ltd1

Indications

  • Cancer3
  • Relapsed/refractory High Grade B Cell Lymphoma1
  • HLA-A*02:01-positive1
  • Diffuse Large B Cell Lymphoma Relapsed1
  • Multiple Myeloma, Relapsed1

Other3 trials

Immunotherapy in Lymphoma
Phase 1/2 Study of IMC-R117C in Selected Advanced Cancers
Phase 1/2
Quality of Life and Treatment Outcomes in RRMM Patients Receiving Advanced vs. Conventional Immunotherapies

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.